"The results indicate that patients who received SACCOVIDTM had a 60% better chance to achieve clinical recovery than those who received placebo (P=0.005). The median time to recovery was 6 days for patients treated with SACCOVIDTM compared with 10 days in the placebo group. In addition, the risk of death or respiratory failure is reduced by more than 50%,” said Dr. Pan Zheng, MD, PhD, Chief Medical Officer and co-founder of OncoImmune."

Seems to me that since no p-value given for mortality unlike for clinical recovery, effect on mortality wasn't stat sig. Oldest trick in biotech...

Anyway, seems they will need another pivotal trial unlike us.